Zyprexa Patent Verdict Coming April 14

Timing of the Indianapolis court's verdict suggests the outcome could be favorable for Lilly. The announcement comes a week after a federal appeals court rescinded a ruling on a Paxil patent that could have aided generic companies' challenges to the olanzapine patent.

More from Archive

More from Pink Sheet